MOOMAW
Scott
Senior Vice President, Commercial at Liquidia Corporation
Organization: Liquidia Corporation
Profession: Senior vice-president
Biography
Moomaw Scott is Senior Vice President, Commercial at Liquidia Corporation.
Career
Mr. Moomaw joined Liquidia in November 2020 from RareGen where he held the position of Chief Operations Officer (COO) since August 2018. Mr. Moomaw is a seasoned leader in biopharmaceuticals with extensive experience launching products and developing commercial strategies and sales organizations. At RareGen he co-founded the company, built the organization, and launched Treprostinil for PAH.
Prior to RareGen Mr. Moomaw was Vice President of Marketing at Opko Health. As Vice President of Marketing for United Therapeutics he had responsibility for Remodulin (parenteral Treprostinil), Tyvaso (inhaled Treprostinil), and Orenitram (oral Treprostinil) for PAH. Mr. Moomaw also held a variety of sales and marketing roles of increasing responsibility at Eli Lilly for over ten years.
Education
Mr. Moomaw holds his MBA from the University of Michigan and a Bachelor of Science (B.S.) from Miami University.